Geron | GERN - Przychody Ze Sprzedaży





Obroty Zmiana Data
Amgen USD 10.1B 1.48B 2026-06
Bio Techne USD 321.2M 9.8M 2026-06
Cytokinetics USD 28.6M 9.25M 2026-06
Exelixis USD 628.69M 17.89M 2026-06
Genmab DKK 1.16B 259M 2026-06
Geron USD 57.48M 5.64M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
Incyte USD 1.67B 400M 2026-06
MacroGenics USD 20.8M 20.43M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Novavax USD 147.14M 76.69M 2025-12